S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
about
Low spinophilin expression enhances aggressive biological behavior of breast cancer.TAp73 transcriptionally represses BNIP3 expression.Epigenetic silencing of S100A2 in bladder and head and neck cancersA BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer
P2860
S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@en
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@nl
type
label
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@en
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@nl
prefLabel
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@en
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@nl
P2093
P2860
P356
P1476
S100A2 is a BRCA1/p63 coregula ...... ation of mutant p53 stability.
@en
P2093
M Kaminska
N E Buckley
P B Mullan
P2860
P356
10.1038/CDDIS.2014.31
P577
2014-02-20T00:00:00Z